Literature DB >> 10760494

Positive and negative modulation of the GABA(A) receptor and outcome after traumatic brain injury in rats.

D M O'Dell1, C J Gibson, M S Wilson, S M DeFord, R J Hamm.   

Abstract

Glutamate-mediated excitotoxicity has been shown to contribute to cellular dysfunction following traumatic brain injury (TBI). Increasing inhibitory function through stimulation of gamma-aminobutyric acid (GABA(A)) receptors may attenuate excitotoxic effects and improve outcome. The present experiment examined the effects of diazepam, a positive modulator at the GABA(A) receptor, on survival and cognitive performance in traumatically brain-injured animals. In experiment 1, 15 min prior to central fluid percussion brain injury, rats (n=8 per group) were injected (i.p.) with saline or diazepam (5 mg/kg or 10 mg/kg). Additional rats (n=8) were surgically prepared but not injured (sham-injury). Rats pre-treated with the 5 mg/kg dose of diazepam had significantly lower mortality (0%) than injured, saline-treated rats (53%). Also, diazepam-treated (5 mg/kg) rats had significantly shorter latencies to reach the goal platform in the Morris water maze test performed 11-15 days post-injury. In experiment 2, at 15 min post-injury, rats were given either saline (n=5) or 5 mg/kg diazepam (n=6). Rats treated with diazepam did not differ in mortality from injured rats treated with vehicle. However, rats treated with diazepam at 15 min post-injury had significantly shorter latencies to reach the goal platform in the Morris water maze than injured, vehicle-treated rats. In experiment 3, the post-injury administration of bicuculline (1.5 mg/kg, n=8), a GABA(A) antagonist, increased Morris water maze goal latencies compared to injured animals treated with saline (n=8). These results suggest that enhancing inhibitory function during the acute post-injury period produces beneficial effects on both survival and outcome following experimental TBI.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10760494     DOI: 10.1016/s0006-8993(00)02055-2

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  16 in total

Review 1.  Elucidating opportunities and pitfalls in the treatment of experimental traumatic brain injury to optimize and facilitate clinical translation.

Authors:  Patricia B de la Tremblaye; Darik A O'Neil; Megan J LaPorte; Jeffrey P Cheng; Joshua A Beitchman; Theresa Currier Thomas; Corina O Bondi; Anthony E Kline
Journal:  Neurosci Biobehav Rev       Date:  2017-05-30       Impact factor: 8.989

Review 2.  Biologic and plastic effects of experimental traumatic brain injury treatment paradigms and their relevance to clinical rehabilitation.

Authors:  Alexandra N Garcia; Mansi A Shah; C Edward Dixon; Amy K Wagner; Anthony E Kline
Journal:  PM R       Date:  2011-06       Impact factor: 2.298

Review 3.  Noninvasive brain stimulation in traumatic brain injury.

Authors:  Asli Demirtas-Tatlidede; Andrew M Vahabzadeh-Hagh; Montserrat Bernabeu; Jose M Tormos; Alvaro Pascual-Leone
Journal:  J Head Trauma Rehabil       Date:  2012 Jul-Aug       Impact factor: 2.710

4.  Suppression of neuronal hyperexcitability and associated delayed neuronal death by adenoviral expression of GABA(C) receptors.

Authors:  Q Cheng; J C Kulli; J Yang
Journal:  J Neurosci       Date:  2001-05-15       Impact factor: 6.167

5.  Genetic variability in glutamic acid decarboxylase genes: associations with post-traumatic seizures after severe TBI.

Authors:  Shaun D Darrah; Megan A Miller; Dianxu Ren; Nichole Z Hoh; Joelle M Scanlon; Yvette P Conley; Amy K Wagner
Journal:  Epilepsy Res       Date:  2012-07-26       Impact factor: 3.045

6.  Valproate administered after traumatic brain injury provides neuroprotection and improves cognitive function in rats.

Authors:  Pramod K Dash; Sara A Orsi; Min Zhang; Raymond J Grill; Shibani Pati; Jing Zhao; Anthony N Moore
Journal:  PLoS One       Date:  2010-06-30       Impact factor: 3.240

7.  Traumatic brain injury and the effects of diazepam, diltiazem, and MK-801 on GABA-A receptor subunit expression in rat hippocampus.

Authors:  Cynthia J Gibson; Rebecca C Meyer; Robert J Hamm
Journal:  J Biomed Sci       Date:  2010-05-18       Impact factor: 8.410

8.  The novel antiepileptic agent RWJ-333369-A, but not its analog RWJ-333369, reduces regional cerebral edema without affecting neurobehavioral outcome or cell death following experimental traumatic brain injury.

Authors:  Carrie A Keck; Hilaire J Thompson; Asla Pitkänen; David G LeBold; Diego M Morales; Jamie B Plevy; Rishi Puri; Boyu Zhao; Marc Dichter; Tracy K McIntosh
Journal:  Restor Neurol Neurosci       Date:  2007       Impact factor: 2.406

Review 9.  Genetic susceptibility to inflammatory injury and various adverse outcomes.

Authors:  John M Murkin; Keith R Walley
Journal:  J Extra Corpor Technol       Date:  2009-03

10.  Glutamate, Glutamine, GABA and Oxidative Products in the Pons Following Cortical Injury and Their Role in Motor Functional Recovery.

Authors:  Laura E Ramos-Languren; Alberto Avila-Luna; Gabriela García-Díaz; Roberto Rodríguez-Labrada; Yaimee Vázquez-Mojena; Carmen Parra-Cid; Sergio Montes; Antonio Bueno-Nava; Rigoberto González-Piña
Journal:  Neurochem Res       Date:  2021-08-13       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.